Regarding patients ́ survival, only VEGFR2 upregulation in ccRCC (favorable prognosis) and downregulation in papillary RCC (favorable prognosis) had a significant impact in the TCGA database. The gene discussed is KDR; the disease is nonpapillary renal cell carcinoma.